Skip to main content
Journal cover image

Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States.

Journal articles  - Journal Article
Niehaus, ED; Kenny, A; Burns, CM; McKellar, MS; Frye, J; Okeke, NL
Published in: AIDS Patient Care STDS
July 2026

Doxycycline postexposure prophylaxis (DoxyPEP) is an emerging strategy to prevent bacterial sexually transmitted infections (STIs) among men who have sex with men (MSM) and transgender women (TGW). We evaluated early DoxyPEP implementation in a university-affiliated infectious diseases clinic providing HIV and pre-exposure prophylaxis (PrEP) care in Durham, North Carolina. This retrospective study included two overlapping cohorts: (1) patients prescribed DoxyPEP through December 31, 2024, to characterize early prescribing and follow-up with contextual clinic comparison; and (2) MSM and TGW diagnosed with a bacterial STI between July 1, 2023, and December 31, 2024, in whom factors associated with DoxyPEP receipt were evaluated using mixed-effects logistic regression. Among 219 patients prescribed DoxyPEP, 41% had a bacterial STI in the preceding year, more frequently among people with HIV (PWH) than PrEP users (51% vs. 30%, p = 0.002). Although PWH comprised 90% of the clinic population, they accounted for 53% of DoxyPEP recipients, signaling disproportionate adoption by HIV status. Among 276 MSM/TGW patients with a bacterial STI during the study period, 26% were prescribed DoxyPEP during a median follow-up of 11 months (interquartile range: 6-14). PrEP use (adjusted odds ratio [aOR]: 11.1, 95% confidence interval [CI]: 2.97-41.2) and encounters after Centers for Disease Control and Prevention guideline release (aOR: 2.46, 95% CI: 1.03-5.83) were associated with DoxyPEP receipt. Recurrent bacterial STI incidence prior to DoxyPEP initiation was 51 per 100 person years. Despite increasing uptake over time, missed opportunities for DoxyPEP prescribing were observed following STI diagnoses, particularly among PWH. Targeted strategies are needed to support integration of DoxyPEP into routine HIV care.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

AIDS Patient Care STDS

DOI

EISSN

1557-7449

Publication Date

July 2026

Volume

40

Issue

8

Start / End Page

288 / 296

Location

United States

Related Subject Headings

  • Young Adult
  • Virology
  • Transgender Persons
  • Sexually Transmitted Diseases, Bacterial
  • Sexual and Gender Minorities
  • Retrospective Studies
  • Pre-Exposure Prophylaxis
  • Post-Exposure Prophylaxis
  • North Carolina
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Niehaus, E. D., Kenny, A., Burns, C. M., McKellar, M. S., Frye, J., & Okeke, N. L. (2026). Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States. AIDS Patient Care STDS, 40(8), 288–296. https://doi.org/10.1177/10872914261461631
Niehaus, Emily D., Avi Kenny, Charles M. Burns, Mehri S. McKellar, Justin Frye, and Nwora Lance Okeke. “Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States.AIDS Patient Care STDS 40, no. 8 (July 2026): 288–96. https://doi.org/10.1177/10872914261461631.
Niehaus ED, Kenny A, Burns CM, McKellar MS, Frye J, Okeke NL. Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States. AIDS Patient Care STDS. 2026 Jul;40(8):288–96.
Niehaus, Emily D., et al. “Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States.AIDS Patient Care STDS, vol. 40, no. 8, July 2026, pp. 288–96. Pubmed, doi:10.1177/10872914261461631.
Niehaus ED, Kenny A, Burns CM, McKellar MS, Frye J, Okeke NL. Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States. AIDS Patient Care STDS. 2026 Jul;40(8):288–296.
Journal cover image

Published In

AIDS Patient Care STDS

DOI

EISSN

1557-7449

Publication Date

July 2026

Volume

40

Issue

8

Start / End Page

288 / 296

Location

United States

Related Subject Headings

  • Young Adult
  • Virology
  • Transgender Persons
  • Sexually Transmitted Diseases, Bacterial
  • Sexual and Gender Minorities
  • Retrospective Studies
  • Pre-Exposure Prophylaxis
  • Post-Exposure Prophylaxis
  • North Carolina
  • Middle Aged